Antiimmunoglobulins of rheumatoid factor (RF) type in prediction of melanoma patients
Lochman, I.; Tvrdík, J.; Lochmanová, A.; Machálek, J.; Vrtná, L.; Kyselá, T.; Beska, F.; Repisták, J.; Konrád, B.; Cesaný, P.
Neoplasma 33(6): 737-741
1986
ISSN/ISBN: 0028-2685 PMID: 3808129 Document Number: 282308
It was found out the titer of antiimmunoglobulins of the rheumatoid factor (RF) type in the sera of melanoma patients can be used in prediction of the development of the patients' status. High titers of antiimmunoglobulins of the RF type, determined by the latex-fixation test (LFT), indicate an unfavorable prognosis in patients with clinical manifestation of uncontrollable recurrence appearing from 1.5 to 2 years after occurrence of the LFT titer.
Document emailed within 1 workday
Related Documents
Grieble, H.; Bach, G.; Anderson, T.; Zschocke, R. 1971: Standardization of the latex fixation test for the demonstration of the rheumatoid factor. 3. Nature of the rheumatoid factor in normal serum, in serum of patients with rheumatoid arthritis, and in serum of the aged Acta Biologica et Medica Germanica 26(1): 185-191Taketazu, F.; Kato, M.; Gobl, A.; Ichijo, H.; ten Dijke, P.; Itoh, J.; Kyogoku, M.; Rönnelid, J.; Miyazono, K.; Heldin, C.H. 1994: Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type Ii receptor in the synovial tissues of patients with rheumatoid arthritis Laboratory Investigation; a Journal of Technical Methods and Pathology 70(5): 620-630
Vlak, T.; Jajić, I. 1992: The effect of gold salts on rheumatoid factor dynamics in patients with rheumatoid arthritis Reumatizam 39(1): 11-13
Kuru, O.; Bilgici, A.; Birinci, A.; Ulusoy, H.; Durupinar, B. 2009: Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis Bratislavske Lekarske Listy 110(10): 650-654
Elson, C.J.; Carter, S.D.; Cottrell, B.J.; Scott, D.G.; Bacon, P.A.; Wallington, T.B. 1985: Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis Clinical and Experimental Immunology 59(2): 285-292
Nonaka, S.; Yasuda, M.; Nobunaga, M. 1993: In vitro IgM rheumatoid factor production by peripheral blood mononuclear cells from patients with seronegative rheumatoid arthritis Journal of Rheumatology 20(9): 1478-1484
Kitani, A.; Hara, M.; Hirose, T.; Norioka, K.; Hirose, W.; Harigai, M.; Suzuki, K.; Kawagoe, M.; Shinmei, M.; Nakamura, H. 1987: Synovial fluids from patients with rheumatoid arthritis possessed B cell differentiation activity contributing to synthesis of rheumatoid factor in vitro Journal of Rheumatology 14(5): 873-879
Juhl, P.; Thudium, C.S.; Gudmann, N.S.; Karsdal, M.A.; Bay-Jensen, A.-C.; Siebuhr, A.S. 2018: IL-6 receptor inhibition modulates type IIi collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of connective tissue turnover in the tocilizumab RADIATE study Clinical and Experimental Rheumatology 36(4): 568-574
Herrmann, D.; Jäger, L.; Hein, G.; Henzgen, M.; Schlenvoigt, G. 1991: IgE rheumatoid factor. Occurrence and diagnostic importance in comparison with IgM rheumatoid factor and circulating immune complexes Journal of Investigational Allergology and Clinical Immunology 1(5): 302-307
Goodwin, J.S.; Ceuppens, J.L.; Rodriguez, M.A. 1983: Administration of nonsteroidal anti-inflammatory agents in patients with rheumatoid arthritis. Effects on indexes of cellular immune status and serum rheumatoid factor levels JAMA 250(18): 2485-2488
Eguchi, K. 2005: Diagnosis and prediction of joint destruction found in patients with rheumatoid arthritis using by biochemical markers Nihon Rinsho. Japanese Journal of Clinical Medicine 63(9): 1586-1593
Sawada, T.; Kanzaki, T.; Hashimoto, S.; Suzuki, A.; Yamada, R.; Odawara, M.; Yamamoto, K. 2009: Citrullinated antigens as C1q-binding and monoclonal rheumatoid factor (mRF)-binding peptides in synovial fluids from rheumatoid arthritis patients Clinical and Experimental Rheumatology 27(6): 989-992
Sihvonen, S.; Korpela, M.; Mustila, A.; Mustonen, J. 2005: The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis Journal of Rheumatology 32(11): 2089-2094
Quartuccio, L.; Mavragani, C.P.; Nezos, A.; Gandolfo, S.; Tzioufas, A.G.; De Vita, S. 2017: Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome Clinical and Experimental Rheumatology 35(4): 719-720
De Filippis, L.; Caliri, A.; Anghelone, S.; Scibilia, G.; Lo Gullo, R.; Bagnato, G. 2006: Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis Panminerva Medica 48(2): 129-135
De Pádua, P.M.; Antunes, L.J. 1973: Latex-seronegative rheumatoid arthritis. Demonstration of the rheumatoid factor: chromatography and dialysis Amb: Revista da Associacao Medica Brasileira 19(10): 389-390
Goodson, N.J.; Farragher, T.M.; Symmons, D.P.M. 2008: Rheumatoid factor, smoking, and disease severity: associations with mortality in rheumatoid arthritis Journal of Rheumatology 35(6): 945-949
Bach, J.F.; Delrieu, F.; Delbarre, F. 1970: Phenomenon of e rheumatoid bow. I. new method of detection of the rheumatoid factor at cellular level La Presse Medicale 78(7): 301-306
Moore, F.L.; Osborn, T.G. 1986: 19S IgM rheumatoid factor plaque forming cells in a five-year-old patient with juvenile rheumatoid arthritis Journal of Rheumatology 13(4): 829-830
Kaipiainen-Seppanen, O.; Kautiainen, H. 2006: Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980-2000 Journal of rheumatology 33(11): 2132-2138